You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 3, 2024

PHOTREXA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Photrexa, and what generic alternatives are available?

Photrexa is a drug marketed by Glaukos and is included in one NDA.

The generic ingredient in PHOTREXA is riboflavin 5'-phosphate. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate profile page.

Drug patent expirations by year for PHOTREXA
Drug Prices for PHOTREXA

See drug prices for PHOTREXA

Recent Clinical Trials for PHOTREXA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Comprehensive EyeCare of Central OhioPhase 4
Glaukos CorporationPhase 4
Avedro, Inc.Phase 4

See all PHOTREXA clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for PHOTREXA

US Patents and Regulatory Information for PHOTREXA

PHOTREXA is protected by zero US patents and two FDA Regulatory Exclusivities.

FDA Regulatory Exclusivity protecting PHOTREXA

TREATMENT OF CORNEAL ECTASIA FOLLOWING REFRACTIVE SURGERY
Exclusivity Expiration: ⤷  Try a Trial

TREATMENT OF PROGRESSIVE KERATOCONUS
Exclusivity Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaukos PHOTREXA riboflavin 5'-phosphate SOLUTION/DROPS;OPHTHALMIC 203324-001 Apr 15, 2016 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaukos PHOTREXA VISCOUS IN DEXTRAN 20% riboflavin 5'-phosphate SOLUTION/DROPS;OPHTHALMIC 203324-002 Apr 15, 2016 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaukos PHOTREXA riboflavin 5'-phosphate SOLUTION/DROPS;OPHTHALMIC 203324-001 Apr 15, 2016 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaukos PHOTREXA VISCOUS IN DEXTRAN 20% riboflavin 5'-phosphate SOLUTION/DROPS;OPHTHALMIC 203324-002 Apr 15, 2016 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.